Work

Real-world effectiveness of dupilumab vs benralizumab and vs mepolizumab in severe asthma: The EU-ADVANTAGE study

Year: 2024

Type: conference-abstract

DOI: 10.1183/13993003.congress-2024.pa2170

Authors: J. Christian Virchow, Giorgio W Canonica, Arnaud Bourdin, Juby Jacob-Nara, Kinga Borsos, Richard H. Stanford, Nami Pandit-Abid, Zhixiao Wang, Mena Soliman, Lynn Huynh, Sarah Kalia, Wendy Cheng

Institutions: Universitätsmedizin Rostock, University of Rostock, IRCCS Humanitas Research Hospital, Centre National de la Recherche Scientifique, Inserm, Université de Montpellier, Physiologie et Médecine Expérimentale du Coeur et des Muscles, Centre Hospitalier Universitaire de Montpellier, Regeneron (United States), Analysis Group (United States)

Language: English

Topic: Asthma and respiratory diseases

Subfield: Physiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4404101087

Cites:

Cited by:

Related to: 10